Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

With subsidiaries in Shanghai, Hangzhou and Beijing, Inmagene strives to be the leading company in immunology-related therapeutic areas in China. The company has been founded by a group of entrepreneurs, including clinicians, scientists and former venture capitalists, who are passionate about novel drug development to fulfill unmet medical needs worldwide. Our pipeline is composed of clinical stage drug candidates with first- ...
With subsidiaries in Shanghai, Hangzhou and Beijing, Inmagene strives to be the leading company in immunology-related therapeutic areas in China. The company has been founded by a group of entrepreneurs, including clinicians, scientists and former venture capitalists, who are passionate about novel drug development to fulfill unmet medical needs worldwide. Our pipeline is composed of clinical stage drug candidates with first- or best-in-class potentials licensed from global partners. Inmagene has also established the capabilities to conduct innovative research and pre-clinical development.

List your booth number for exhibitions, ask us